Frontier Medicines | ApexOnco - Clinical Trials news and analysis

x

“The insights provided by the analysts are great”

Andrea Gnirke-Maier

Director New Product Planning

Morphosys

Click here for more information

Trial results

8 February 2024

KRAS and conjugates remain hot

The latest clinical study listings reveal KRAS-targeting projects, ADCs and others starting phase 1.

Subscribe to Frontier Medicines